Search Clinical Trials
By Condition
By Location (USA)
By Location (Other)
By Sponsor
Resources
Privacy Policy
About Us
Disclaimer
Ohio Refractory Chronic Lymphocytic Leukemia Clinical Trials Data presented on Clinical Trials Search isn't meant to be a substitute for proven health advice, trips or treatment using a real doctor. We aren't mDs. Always consult your local Ohio Refractory Chronic Lymphocytic Leukemia physician on conditions. Clinical Trials Search.org is a website dedicated to listing clinical research studies in human subjects. Ohio Refractory Chronic Lymphocytic Leukemia Clinical research trials and Ohio Refractory Chronic Lymphocytic Leukemia health trials take place in many of Ohio places. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally assess the potency of new drugs. The intention of the studies / undertakings is to answer certain human healthcare questions. Clinical trials are a popular way for mDs, government agencies, and private sector companies to detect cures for all kinds of conditions. Ohio Refractory Chronic Lymphocytic Leukemia Clinical Trials and other clinical trials permit volunteers to acquire medical treatment alternatives before they are available to the masses. Some times the participants get treatment for without cost, and every now and again they are paid for their time. Sometimes there is a cost for a Ohio Refractory Chronic Lymphocytic Leukemia clinical trial. Test subjects oftentimes recieve the most effective healthcare available for their condition. Hazards are a reality, however, and could include additional or frequent doctor visits, healthcare dangers (possibly life-jeopardizing), and/or the treatment being ineffective. Trials are federally governed with stern guidelines to protect clinical trials subjects.

Home > Ohio Clinical Trials > Ohio Refractory Chronic Lymphocytic Leukemia Clinical Trials

Ohio Refractory Chronic Lymphocytic Leukemia Clinical Trials



506U78 in Treating Patients With Chronic Lymphocytic Leukemia That Has Not Responded to Fludarabine or Alkylating Agents
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

Combination Chemotherapy in Treating Patients With Chronic Lymphocytic Leukemia, Non-Hodgkin's Lymphoma, or Multiple Myeloma
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

Compassionate Use Program of Campath-1H in Patients With Refractory Prolymphocytic Leukemia or Chronic Lymphocytic Leukemia
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

Decitabine and Valproic Acid in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Previously Treated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Condition: arthur_g_james_cancer_hospital__richard_j_solove_research_institute_clinical_trials.html
Arthur G. James Cancer Hospital & Richard J. Solove Research Institute

Flavopiridol in Treating Patients With Chronic Lymphocytic Leukemia
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

Flavopiridol in Treating Patients With Previously Treated Chronic Lymphocytic Leukemia or Lymphocytic Lymphoma
Condition: arthur_g_james_cancer_hospital__richard_j_solove_research_institute_clinical_trials.html
Arthur G. James Cancer Hospital & Richard J. Solove Research Institute

FR901228 in Treating Children with Refractory or Recurrent Solid Tumors or Leukemia
Condition: childrens_oncology_group_clinical_trials.html
Children's Oncology Group

FR901228 in Treating Patients With Hematologic Cancer
Condition: arthur_g_james_cancer_hospital__richard_j_solove_research_institute_clinical_trials.html
Arthur G. James Cancer Hospital & Richard J. Solove Research Institute

Monoclonal Antibody Therapy in Treating Patients With Chronic Lymphocytic Leukemia, Lymphocytic Lymphoma, Acute Lymphoblastic Leukemia, or Acute Myeloid Leukemia
Condition: arthur_g_james_cancer_hospital__richard_j_solove_research_institute_clinical_trials.html
Arthur G. James Cancer Hospital & Richard J. Solove Research Institute

Oblimersen in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
Condition: genta_clinical_trials.html
Genta

Thalidomide in Treating Patients With Relapsed Chronic Lymphocytic Leukemia
Condition: north_central_cancer_treatment_group_clinical_trials.html
North Central Cancer Treatment Group



Ohio Refractory Chronic Lymphocytic Leukemia Clinical Trials

Modify your Search

Clinical Trials by Ohio City:

Akron
Athens
Avon Lake
Beachwood
Beavercreek
Beechwood
Bellbrook
Bowling Green
Brecksville
Bryan
Canfield
Canton
Centerville
Chagrin Falls
Chardon
Chillicothe
Cincinnati
Cleveland
Columbus
Cuyahoga Falls
Dayton
Delaware
Dover
Dublin
Elyria
Fairview Park
Findlay
Fremont
Grove City
Hamilton
Independence
Kenton
Kettering
Lakewood
Lancaster
Lima
Lorain
Lorraine
Lyndhurst
Manfield
Mansfield
Marietta
Marion
Mason
Maumee
Mayfield Heights
Mayfield Village
Medina
Mentor
Middleburg Heights
Middletown
Mogadore
Mogadorf
Mount Vernon
Newark
Norwood
Oregon
Parma
Poland
Portland
Salem
Sandusky
Springfield
Sylvania
Toledo
Troy
Uniontown
University Heights
Wadsworth
Warren
Warrensville Heights
Wauseon
West Chester
Westerville
Willoughby
Wooster
Xenia
Youngstown
Zanesville

Other Ohio Clinical Trials by Condition:

Refractory Chronic Lymphocytic Leukemia
Refractory Chronic Lymphocytic Leukemia
Refractory Chronic Lymphocytic Leukemia
Refractory Chronic Lymphocytic Leukemia


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103